Supernus Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SUPN and other ETFs, options, and stocks.About SUPN
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products.
SUPN Key Statistics
Stock Snapshot
With a market cap of 2.84B, Supernus Pharmaceuticals(SUPN) trades at $49.39. The stock has a price-to-earnings ratio of -74.31.
As of 2026-03-18, Supernus Pharmaceuticals(SUPN) stock has fluctuated between $48.91 and $50.72. The current price stands at $49.39, placing the stock +1.0% above today's low and -2.6% off the high.
Supernus Pharmaceuticals(SUPN) shares are trading with a volume of 293.61K, against a daily average of 642.19K.
During the past year, Supernus Pharmaceuticals(SUPN) stock moved between $29.16 at its lowest and $59.68 at its peak.
During the past year, Supernus Pharmaceuticals(SUPN) stock moved between $29.16 at its lowest and $59.68 at its peak.
SUPN News
New insider activity at Supernus Pharmaceuticals ( (SUPN) ) has taken place on March 16, 2026. Director Frederick Hudson of Supernus Pharmaceuticals has recent...
Advertisement What recent performance tells you about Supernus Pharmaceuticals Supernus Pharmaceuticals (SUPN) has drawn investor attention after recent tradi...
Analyst ratings
83%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.